These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28645721)

  • 1. Comparison of different inactivation methods on the stability of Indian vaccine strains of foot and mouth disease virus.
    Sarkar A; Tamil Selvan RP; Kishore S; Ganesh K; Bhanuprakash V
    Biologicals; 2017 Jul; 48():10-23. PubMed ID: 28645721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde.
    Barteling SJ; Cassim NI
    Dev Biol (Basel); 2004; 119():449-55. PubMed ID: 15742659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of binary ethyleneimine (BEI) used as an inactivant for foot and mouth disease tissue culture vaccine.
    Aarthi D; Ananda Rao K; Robinson R; Srinivasan VA
    Biologicals; 2004 Sep; 32(3):153-6. PubMed ID: 15536046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of infectious bursal disease virus by binary ethylenimine and formalin.
    Habib M; Hussain I; Fang WH; Rajput ZI; Yang ZZ; Irshad H
    J Zhejiang Univ Sci B; 2006 Apr; 7(4):320-3. PubMed ID: 16532536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrity of GH-loop of foot-and-mouth disease virus during virus inactivation: detection by epitope specific antibodies.
    Patil PK; Suryanarayana V; Bist P; Bayry J; Natarajan C
    Vaccine; 2002 Jan; 20(7-8):1163-8. PubMed ID: 11803078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of γ-radiation and ultraviolet as a new inactivators for foot and mouth disease virus in comparison with the traditional methods.
    Mahdy Sel D; Hassanin AI; Gamal El-Din WM; Ibrahim Eel-S; Fakhry HM
    Vet World; 2015 Sep; 8(9):1088-98. PubMed ID: 27047204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Using size-exclusion chromatography to quantify the 146S antigen in inactivated foot-and-mouth disease vaccine].
    Xu Y; Zou X; Li C; Zhu Y; He T; Yang Y; Lin X; Song Y; Zheng J; Zhang S; Zhao Q
    Sheng Wu Gong Cheng Xue Bao; 2018 May; 34(5):676-684. PubMed ID: 29893075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles.
    Harmsen MM; Fijten HP; Westra DF; Coco-Martin JM
    Vaccine; 2011 Mar; 29(15):2682-90. PubMed ID: 21316500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
    Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a binary ethylenimine (BEI) inactivation procedure for biosafety treatment of foot-and-mouth disease viruses (FMDV), vesicular stomatitis viruses (VSV), and swine vesicular disease virus (SVDV).
    Wu P; Rodríguez YY; Hershey BJ; Tadassa Y; Dodd KA; Jia W
    Vet Microbiol; 2021 Jan; 252():108928. PubMed ID: 33248402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Three Types of Inactivation Agents on the Antibody Response and Immune Protection of Inactivated IHNV Vaccine in Rainbow Trout.
    Tang L; Kang H; Duan K; Guo M; Lian G; Wu Y; Li Y; Gao S; Jiang Y; Yin J; Liu M
    Viral Immunol; 2016 Sep; 29(7):430-5. PubMed ID: 27548006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization study of inactivated foot and mouth disease virus vaccine by size-exclusion HPLC and differential scanning calorimetry.
    Yang Y; Zhao Q; Li Z; Sun L; Ma G; Zhang S; Su Z
    Vaccine; 2017 Apr; 35(18):2413-2419. PubMed ID: 28342666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B; Visser N; Theron J; Rieder E; Maree FF
    J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of chemical extraction methods for determination of 146S content in foot-and-mouth disease oil-adjuvanted vaccine.
    Saravanan P; Iqbal Z; Selvaraj DPR; Aparna M; Umapathi V; Krishnaswamy N; Tamilselvan RP
    J Appl Microbiol; 2020 Jan; 128(1):65-73. PubMed ID: 31562676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Acta Virol; 1992 Oct; 36(5):473-8. PubMed ID: 1364024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study on the immune response of sheep to foot and mouth disease virus vaccine type Asia-1 prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Comp Immunol Microbiol Infect Dis; 1992 Apr; 15(2):117-24. PubMed ID: 1314158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilizing effects of excipients on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles during storage as oil-emulsion vaccine.
    Harmsen MM; Fijten HP; Westra DF; Dekker A
    Vaccine; 2015 May; 33(21):2477-84. PubMed ID: 25843267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenging settled opinions in classic foot-and-mouth disease vaccine preparation.
    Barteling SJ; Anemaet DA
    Dev Biol Stand; 1987; 66():531-8. PubMed ID: 3034709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cell density on the biological titer and yield of 146S fraction of foot-and-mouth disease virus O in cell suspension.
    Rizvi A; Hussain N; Anjum AA; Ahmed N; Naeem A; Khan M; Altaf I
    J Virol Methods; 2022 Feb; 300():114379. PubMed ID: 34826516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of foot-and-mouth disease virus antigen by surface-enhanced laser desorption ionization-time of flight-mass spectrometry in aqueous and oil-emulsion formulations.
    Harmsen MM; Jansen J; Westra DF; Coco-Martin JM
    Vaccine; 2010 Apr; 28(19):3363-70. PubMed ID: 20206283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.